Director, US Scientific Marketing – Melanoma

USA (Remote)

$250K/yr – $265K/yrDirector/Executive12+ years expFull time

Posted 2 hrs ago

Job Description

Responsibilities

  • The Scientific P2P & MedEd Marketing Lead will be responsible for the success of an expansive P2P education and promotion platform, encompassing speaker programs, clinical experience roundtables, advisory boards, and other activities.
  • This role requires senior level marketing expertise and strong strategic and analytical thinking as well as creativity and decision-making skills.
  • P2P (Peer-to-Peer) strategy, planning, and execution
  • Develop educational content consistent with overall brand strategy to drive impactful peer to peer engagements.
  • Lead national and regional peer to peer programming and execution, including development of speaker program materials and coordination with sales leads.
  • Partner with Medical Affairs to provide commercial perspective on publications, scientific communications, and real-world evidence/ HEOR data generation.
  • Ensure that all marketing activities are in compliance with regulatory and legal requirements.
  • Must adhere to Iovance Biotherapeutics’ core values, policies, procedures, and business ethics.
  • Perform miscellaneous duties as assigned.
  • Travel – 30%

Requirements

  • 12+ years of relevant marketing or related healthcare experience required.
  • A bachelor’s degree in marketing or related fields is required.
  • Knowledge of oncology drug development and understanding of melanoma disease
  • Demonstrated ability to own and execute commercial facing scientific marketing strategy in a resource-lean fast moving biotech environment.
  • Awareness of competitive dynamics, emerging science and trends within melanoma and immuno-oncology
  • Practical experience in biotech or pharmaceutical commercial functions, preferably within small or mid-size organizations.
  • Hands on ability developing scientific marketing strategies aligned with brand objectives.
  • Comfort operating with limited infrastructure, taking initiative, and driving workstreams independently while collaborating cross-functionally.
  • Strategic thinking
  • Strong prioritization and execution skills, with the ability to adapt quickly to changing data, timelines, and business needs.

Preferred

  • Cell Therapy experience is desirable.
  • An advanced science degree such as MD, PharmD, PhD or an advanced business degree such as an MBA is desirable.
Iovance Biotherapeutics logo

Iovance Biotherapeutics

2.6 Glassdoor

Iovance Biotherapeutics (NASDAQ: IOVA) aims to be the global leader in innovating, developing and delivering tumor infiltrating lymphocyte (TIL) therapies for patients with cancer. We are pioneering a transformational approach to cure cancer by harnessing the human immune system’s ability to recognize and destroy diverse cancer cells in each patient. The Iovance TIL platform has demonstrated promising clinical data across multiple solid tumors. We are committed to continuous innovation in cell therapy, including gene-edited cell therapy, that may extend and improve life for patients with cancer.We are adding to our talented team as we execute our commercial launch, advance our research and development efforts, and build our internal manufacturing capabilities. Iovance is headquartered in the San Francisco Bay Area. Our Iovance Cell Therapy Center (iCTC), a state-of-the-art manufacturing facility, is located in Philadelphia. We also have a research site in Tampa, Florida. Any information expressed by Iovance is subject to the risk factors and information on forward-looking statements contained in its filings with the Securities and Exchange Commission and available here: https://ir.iovance.com/sec-filings

Founded in 2007
San Carlos, California, USA
931 employees
0% recommend to a friend
0% CEO approval

Salaries

Posted range

$250K/yr – $265K/yr

Taken straight from the job posting.

See all Iovance Biotherapeutics salaries

Marketing Team

Marketing Roles Posted (Last 30 Days)
1

Funding

Total Funding
$1.6B
Last Raise
$211M
Post IPO Equity

Funding History

  • Feb 2024
    Post IPO Equity • $211M
  • Jul 2023
    Post IPO Equity • $150M
  • May 2020
    Post IPO Equity • $603.7M

Traffic Signals

Monthly Visitors
28.8K
Traffic Source Mix
Search
48.2%
Direct
49.2%
Referral
2.6%

Headcount Trend

Current headcount: ~931

Recent News

Iovance Biotherapeutics logo

Director, US Scientific Marketing – Melanoma

Iovance Biotherapeutics · USA · Remote